Single-dose granulocyte colony-stimulating factor concomitant with multifractionated dose chemotherapy: a strategy for maintaining dose intensity.

Abstract:

:Multifractionated dosing (MFD) schedules for chemotherapy administration such as weekly or twice weekly administration are intended to maximize dose intensity while minimizing toxicity, but the cumulative drug effect may result in neutropenia necessitating interruption of dose fractions and thereby compromising dose intensity. Intermittent granulocyte colony-stimulating factor (G-CSF, Neupogen, Amgen) was administered to patients receiving MFD on three paclitaxel-based chemotherapy regimens. Single-dose G-CSF was administered concomitant with the chemotherapy dose fraction when the white blood count was between 2000 and 3500 cells/microliter. A retrospective analysis of the concomitant administration of single-dose G-CSF with chemotherapy in these trials demonstrated that in most patients, G-CSF administration guided by the level or grade of leukopenia permitted maintenance of the chemotherapy dose intensity and completion of the treatment cycle. The common pattern in a six-dose, twice weekly, multifractionated cycle was for G-CSF to be administered with every other chemotherapy dose beginning with the third, fourth, or fifth dose, but some courses required G-CSF administration with each chemotherapy dose fraction. Guidelines for the concomitant use of G-CSF and paclitaxel-based MFD chemotherapy can be used to maintain chemotherapy dose intensity. A prospective study of guidelines for cytokine usage developed on the basis of this retrospective study will be necessary to determine the optimal cytokine dose and schedule for use simultaneously with chemotherapy.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Lokich J

doi

10.3109/07357909909032865

subject

Has Abstract

pub_date

1999-01-01 00:00:00

pages

547-50

issue

7

eissn

0735-7907

issn

1532-4192

journal_volume

17

pub_type

杂志文章
  • Glyoxalase I Glu111Ala polymorphism in patients with breast cancer.

    abstract::Effect of advanced glycation end products (AGEs) in the pathogenesis of cancer could be diminished by interaction with soluble RAGE or by reducing AGE-precursors via glyoxalase I. Glu111Ala polymorphism of glyoxalase I gene, AGEs, and sRAGE serum levels were studied in 113 breast cancer patients and in 58 controls. Hi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802350822

    authors: Germanová A,Germanová A,Tesarová P,Jáchymová M,Zvára K,Zima T,Kalousová M

    更新日期:2009-07-01 00:00:00

  • Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials.

    abstract::There appears to be exceptional and growing public enthusiasm for botanical, or "herbal", medicines, especially amongst cancer patients. This has recently begun to be matched by increasing scientific attention. Whilst it is known that plant extracts are active against cancer, the standard approach has been to isolate,...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120005926

    authors: Vickers A

    更新日期:2002-01-01 00:00:00

  • Novel Quinoxaline-2-Carbonitrile-1,4-Dioxide Derivatives Suppress HIF1α Activity and Circumvent MDR in Cancer Cells.

    abstract::A series of 3-aryl/hetarylquinoxaline-2-carbonitrile-1,4-dioxides was synthesized and evaluated against breast cancer cell lines in normoxia and hypoxia. Selected compounds in this series demonstrated better cytotoxicity and comparable hypoxia selectivity than tirapazamine. In contrast to Dox, quinoxaline-1,4-dioxides...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2018.1453072

    authors: Scherbakov AM,Borunov AM,Buravchenko GI,Andreeva OE,Kudryavtsev IA,Dezhenkova LG,Shchekotikhin AE

    更新日期:2018-03-16 00:00:00

  • Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population.

    abstract::This case control study investigated whether polymorphisms of estrogen metabolizing genes CYP1A1 MspI, CYP17 MspAI, COMT Val(158) Met, and SULT1A1 Arg(213) His have any role in familial breast cancer susceptibility risk. Logistic regression analysis adjusted to age was used to calculate odds ratios (ORs) and 95% confi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900902744494

    authors: Syamala VS,Syamala V,Sheeja VR,Kuttan R,Balakrishnan R,Ankathil R

    更新日期:2010-03-01 00:00:00

  • Chemiluminescence production by neutrophils and immune complex levels in cancer patients.

    abstract::We studied the production of chemiluminescence (CL) by peripheral blood neutrophils from 24 normal subjects, 13 lung cancer patients with clinical stages (CS) III and IV, and 27 breast cancer patients with CS II, III, and IV. Evaluations were made before chemo- and radiotherapy treatments. CL was expressed as: baselin...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909309011669

    authors: Chasseing NA,Barañao RI,Fernández O,Bordenave H,Rumi LS

    更新日期:1993-01-01 00:00:00

  • Methylated tumor-specific DNA as a plasma biomarker in patients with glioma.

    abstract:OBJECTIVE:Patients with systemic malignancies have substantial quantities of tumor-specific DNA in their plasma which may serve as a potential biomarker for tumor burden. This approach has not been studied in gliomas. METHODS:Methylation specific polymerase chain reaction (MSP) was used to determine the methylation st...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900500449546

    authors: Weaver KD,Grossman SA,Herman JG

    更新日期:2006-02-01 00:00:00

  • CD133 negatively regulates tumorigenicity via AKT pathway in synovial sarcoma.

    abstract::Synovial sarcoma (SS) is an aggressive tumor that accounts for almost 10% of all soft tissue sarcomas. In this study, we found the expression of CD133 in human SS specimens, thus, we focused on the function of CD133 in SS. Separation of the CD133-positive and -negative subpopulations in SS cell lines clarified that th...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2012.672607

    authors: Kimura T,Wang L,Tabu K,Nishihara H,Mashita Y,Kikuchi N,Tanino M,Hiraga H,Tanaka S

    更新日期:2012-06-01 00:00:00

  • Apoptosis-inducing effects of Melissa officinalis L. essential oil in glioblastoma multiforme cells.

    abstract::Current therapies for glioblastoma multiforme (GBM) are not effective. This study investigated the activity of the M. officinalis essential oil (EO) and its major component (citral) in GBM cell lines. Both EO and citral decreased the viability and induced apoptosis of GBM cells as demonstrated by DNA fragmentation and...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2014.905587

    authors: Queiroz RM,Takiya CM,Guimarães LP,Rocha Gda G,Alviano DS,Blank AF,Alviano CS,Gattass CR

    更新日期:2014-07-01 00:00:00

  • Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Outcome of Immune Checkpoint Inhibitors.

    abstract::A meta-analysis of 14 studies (16 cohorts) incorporating 1751 participants was performed to evaluate the correlation between baseline neutrophil-to-lymphocyte ratio (NLR) and outcome of immune checkpoint inhibitors (ICI). The pooled hazard ratio (HR) suggested elevated pretreatment NLR was associated with poor OS (HR:...

    journal_title:Cancer investigation

    pub_type: 杂志文章,meta分析

    doi:10.1080/07357907.2019.1639057

    authors: Xie X,Liu J,Yang H,Chen H,Zhou S,Lin H,Liao Z,Ding Y,Ling L,Wang X

    更新日期:2019-01-01 00:00:00

  • Phase II evaluation of amonafide in advanced sarcoma: a Southwest Oncology Group study.

    abstract::Soft tissue sarcomas are generally resistant to most chemotherapeutic agents, and individuals with advanced disease have a poor prognosis. We evaluated amonafide, a new drug that has significant activity against several tumor cell lines, to determine its activity against sarcomas. Amonafide was administered to 18 pati...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.3109/07357909409038230

    authors: Buys SS,Metch B,Balcerzak SP,Neefe JR,Stuckey WJ

    更新日期:1994-01-01 00:00:00

  • ErbB receptors as prognostic and therapeutic drug targets in bone and soft tissue sarcomas.

    abstract::ErbB receptors have been intensely studied to understand their importance in cancer biology and as therapeutic targets, and many ErbB inhibitors are now used in the clinical setting. A large number of studies have been conducted to examine the expression of ErbB family members in bone and soft tissue sarcomas, includi...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2014.964409

    authors: Wang H,Yang Q,Fu Z,Zuo D,Hua Y,Cai Z

    更新日期:2014-12-01 00:00:00

  • A phase I study of gemcitabine and docetaxel for advanced stage solid tumors.

    abstract:BACKGROUND:We conducted a phase I study to determine the maximum tolerated dose of docetaxel in combination with gemcitabine for patients with refractory solid tumors. METHODS:From January 1998 to November 1999, we treated 28 patients on a phase I protocol with gemcitabine given at a constant dose of 800 mg/m2 i.v. ov...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.1081/cnv-120018225

    authors: Poole ME,Bernard SA,Churchel MA,Weissler MC,Calvo B,Cance W,Ollila D,Koruda M,Behrns K,Detterbeck FC

    更新日期:2003-06-01 00:00:00

  • The prognostic impact of bone marrow micrometastases in women with breast cancer.

    abstract::Metastasis is the overwhelming cause of mortality in patients with breast cancer and our understanding of its cellular and molecular determinants is limited. Among cellular determinants, disseminated (DTC) tumor cells undoubtedly are key players in the metastatic cascade. In the past, several models have been construc...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900802574496

    authors: Braun S,Auer D,Marth C

    更新日期:2009-07-01 00:00:00

  • A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer.

    abstract::Despite increasing evidence of benefit from adjuvant chemotherapy, older women with breast cancer are commonly given less aggressive treatment than younger patients. Conflicting prior data regarding age-related toxicity prompted this prospective study. Forty-four women (aged 35-79 years) with early-stage breast cancer...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900009012191

    authors: Dees EC,O'Reilly S,Goodman SN,Sartorius S,Levine MA,Jones RJ,Grochow LB,Donehower RC,Fetting JH

    更新日期:2000-01-01 00:00:00

  • Polymorphic AAAG repeat length in estrogen-related receptor gamma (ERRγ) and risk of breast cancer in Iranian women.

    abstract::Estrogen-related receptors (ERRs) alpha, beta, and gamma are orphan nuclear receptors that modulate the estrogen signaling pathway and play roles in the regulation of breast cancer cell growth. To determine the association between breast cancer risk and alleles of the tetranucleotide repeat (AAAG)n in the intron of ER...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.845672

    authors: Karimi P,Hematti S,Safari F,Tavassoli M

    更新日期:2013-11-01 00:00:00

  • Severe Treatment-Related Lymphopenia in Patients with Newly Diagnosed Rectal Cancer.

    abstract:BACKGROUND:Although treatment-related lymphopenia (TRL) is common in many cancers no data exists in rectal cancer. METHODS:Serial lymphocyte counts were analyzed retrospectively in patients with newly diagnosed rectal cancer, serial blood counts, and complete records at Johns Hopkins Hospital. RESULTS:Fifty-seven pat...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2018.1499028

    authors: Campian JL,Ye X,Sarai G,Herman J,Grossman SA

    更新日期:2018-01-01 00:00:00

  • Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.

    abstract::We have analyzed allelic loss of the short arm of chromosome 9 in 39 head and neck cancers using 13 polymorphic markers and found two deletions of hot spots at 9p21 and 9p24. Loss of heterozygosity was detected at least at one locus in 28 of 39 cases (71.8%). P16, a well-known tumor suppressor gene, is considered to b...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802563010

    authors: Gunduz E,Gunduz M,Ali MA,Beder L,Tamamura R,Katase N,Tominaga S,Yamanaka N,Shimizu K,Nagatsuka H

    更新日期:2009-07-01 00:00:00

  • Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma.

    abstract::Glioma stem cells (GSCs) play major roles in drug resistance, tumour maintenance and recurrence of glioblastoma. We investigated inhibition of the GTPase dynamin 2 as a therapy for glioblastoma. Glioma cell lines and patient-derived GSCs were treated with dynamin inhibitors, Dynole 34-2 and CyDyn 4-36. We studied abou...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1582060

    authors: Luwor R,Morokoff AP,Amiridis S,D'Abaco G,Paradiso L,Stylli SS,Nguyen HPT,Tarleton M,Young KA,O'Brien TJ,Robinson PJ,Chircop M,McCluskey A,Jones NC

    更新日期:2019-01-01 00:00:00

  • Tumor suppressor proteins are differentially affected in human ependymoblastoma and medulloblastoma cells exposed to nerve growth factor.

    abstract::The aim of our study was to investigate the role of nerve growth factor (NGF) on the expression of the p73 protein in human ependymoblastoma (EP) and medulloblastoma (MB) cells. It was found that NGF exposure on MB cells blocks proliferation, as well as on EP cells and induces overexpression of p73. NGF reduces the nu...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701205689

    authors: Antonelli A,Lenzi L,Nakagawara A,Osaki T,Chiaretti A,Aloe L

    更新日期:2007-03-01 00:00:00

  • 5-Aza-2'-deoxycytidine restores proapoptotic function of p53 in cancer cells resistant to p53-induced apoptosis.

    abstract::The expression of p53-target genes encoding the proapoptotic factor Noxa, but not PUMA, was not induced by p53 in HCT116 and SW480 cells, which show resistance to apoptosis in response to p53 overexpression. The lack of p53 inducibility of Noxa was restored by treatment with the DNA methyltransferase inhibitor 5-Aza-2...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701840212

    authors: Yagi S,Oda-Sato E,Uehara I,Asano Y,Nakajima W,Takeshita T,Tanaka N

    更新日期:2008-08-01 00:00:00

  • Treatment of advanced malignancies with high-dose acetaminophen and N-acetylcysteine rescue.

    abstract::High-dose acetaminophen (HDAC) produces hepatocellular necrosis and cytotoxic changes in other tissues that express mixed-function-oxidase (MFO) activity. N-acetylcysteine (NAC), administered within 8 hr of HDAC exposure, replenishes reduced glutathione and prevents these effects. Numerous cell culture and animal stud...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909609012140

    authors: Kobrinsky NL,Hartfield D,Horner H,Maksymiuk A,Minuk GY,White DF,Feldstein TJ

    更新日期:1996-01-01 00:00:00

  • Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values.

    abstract::Pancreatic cancer is the fourth leading cause of cancer death with a 5-year survival less than 5 percent despite rigorous interventions. This largely is due to its late presentation, aggressive metastasis, and a lack of effective adjuvant therapies. Cytokines have been studied in many tumor types, where they have been...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900600981398

    authors: Feurino LW,Fisher WE,Bharadwaj U,Yao Q,Chen C,Li M

    更新日期:2006-11-01 00:00:00

  • A Review of Quality of Life Measures used in Surgical Outcomes for Stage I Lung Cancers.

    abstract::This review summarizes the literature on QoL in early stage lung cancer patients who underwent surgery. PubMed and PsycINFO were searched. Twelve articles from 10 distinct studies were identified for a total of 992 patients. Five QoL measures were used. One study reported only on pre-surgical QoL, six only on post-sur...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357907.2018.1474892

    authors: Yip R,Taioli E,Schwartz R,Li K,Becker BJ,Tam K,Htwe YM,Yankelevitz DF,Henschke CI

    更新日期:2018-01-01 00:00:00

  • DNA biomarkers antecede semiquantitative anthracycline cardiomyopathy.

    abstract::Adriamycin (ADM, or doxorubicin hydrochloride) is an effective antineoplastic agent whose use is restricted by its well-described, dose-dependent cardiotoxicity. This study measures ADM DNA adduct formation by 32P-radiolabeling DNA, enzymatically digesting radiolabeled DNA, separating the formed adducts on two-dimensi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-120016404

    authors: Hahm S,Dresner HS,Podwall D,Golden M,Winiarsky R,Moosikasuwan M,Cajigas A,Steinberg JJ

    更新日期:2003-01-01 00:00:00

  • Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.

    abstract::We analyzed the pattern of alpha-fetoprotein (AFP) synthesis in 40 consecutive human hepatocarcinomas (HCC) in relation to hepatitis B viral (HBV) infection. In addition, histopathological characteristics of liver parenchyma and the tumor itself were examined. Elevated AFP (> 20 ng/ml) were found in 90% of HCC patient...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909209024813

    authors: Kashala LO,Kalengayi MM,Essex M

    更新日期:1992-01-01 00:00:00

  • Expression of decorin in esophageal cancer in relation to the expression of three isoforms of transforming growth factor-beta (TGF-beta1, -beta2, and -beta3) and matrix metalloproteinase-2 activity.

    abstract::To determine the role of the reactive stroma in cancer progression, we investigated decorin (DCN) and transforming growth factor-beta (TGF-beta expression, and matrix metalloproteinase-2 (MMP-2) activity in the tumorous esophagus. We found statistically insignificantly decreased levels of DCN expression in the patholo...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802527221

    authors: Augoff K,Grabowski K,Rabczynski J,Kolondra A,Tabola R,Sikorski AF

    更新日期:2009-05-01 00:00:00

  • Association of polymorphisms in regulatory regions of interleukin-12p40 gene and cytokine serum level with colorectal cancer.

    abstract::The present study investigates the association between IL12Bpro and +16974A/C in 3' -untranslated region (UTR) polymorphisms of IL12B and IL-12p40 serum level related to development of colorectal cancer (CRC). Our results showed similar distribution of both the investigated polymorphisms among CRC patients and healthy...

    journal_title:Cancer investigation

    pub_type: 杂志文章,多中心研究

    doi:10.3109/07357900902918486

    authors: Miteva L,Stanilov N,Deliysky T,Mintchev N,Stanilova S

    更新日期:2009-11-01 00:00:00

  • ZBTB7 overexpression contributes to malignancy in breast cancer.

    abstract::ZBTB7 was recently recognized as a proto-oncogene. We studied its prognostic value and relationship to clinicopathological variables in 125 breast cancer patients. ZBTB7 expression was significantly higher in breast cancer tissues than in normal breast tissues, but its gene amplification copies were relatively low. ZB...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357901003631007

    authors: Qu H,Qu D,Chen F,Zhang Z,Liu B,Liu H

    更新日期:2010-07-01 00:00:00

  • Interferon-α induces G1 cell-cycle arrest in renal cell carcinoma cells via activation of Jak-Stat signaling.

    abstract::The purpose of this study was to clarify the mechanism of IFN-α resistance in RCC. The effects of IFN-α on induction of apoptosis and cell-cycle arrest were analyzed by flow cytometric analysis. Jak-Stat pathway components induced by IFN-α was evaluated using Western blotting. The results suggested that IFN-α caused g...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.568566

    authors: Shang D,Yang P,Liu Y,Song J,Zhang F,Tian Y

    更新日期:2011-06-01 00:00:00

  • Combination chemotherapy specifically devised for elderly patients with unfavorable non-Hodgkin's lymphoma.

    abstract::The results of a prospective trial with a specifically devised chemotherapy regimen in elderly patients with unfavorable non-Hodgkin's lymphoma (NHL) are reported. Between April 1983 and April 1986, 37 consecutive patients 70 years old or more (median age 80) received etoposide and prednimustine (E + P) 100 mg/m2 p.o....

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909009018923

    authors: Zagonel V,Tirelli U,Carbone A,Errante D,Morassot S,Sorio R,Monfardini S

    更新日期:1990-01-01 00:00:00